Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy

American Journal of Hematology

Volumn 78, Issue 2, 2005, Pages 127-129

  Ahn, Eugene R ^a   Lander, Gabriella ^a   Bidot, Carlos J ^a   Jy, Wenche ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Antiphospholipid antibody syndrome; Hypercoagulable state; Lupus anticoagulant; Rituximab; Thrombosis

Indexed keywords

ARGATROBAN; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; HEPARIN; IMMUNOGLOBULIN M ANTIBODY; LEPIRUDIN; LUPUS ANTICOAGULANT; RITUXIMAB; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BONE DISEASE; BONE INFARCTION; BUDD CHIARI SYNDROME; CASE REPORT; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HYPERCOAGULABILITY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFARCTION; LUNG EMBOLISM; MESENTERIC VEIN THROMBOSIS; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; STROKE; SUBDURAL HEMATOMA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; CRITICAL ILLNESS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; RECURRENCE; REMISSION INDUCTION; THROMBOPHILIA; TREATMENT FAILURE; VASCULAR DISEASES; WARFARIN;

EID: 13244275118     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20212     Document Type: Article

References (6)

1. Alving BM. Diagnosis and management of patients with the antiphospholipid syndrome. J Thromb Thrombolysis 2001;12:89-93.
2. Horbach DA, Van Oort E, Donders RC, Derksen RH, De Groot PG. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 1996;76:916-924.
3. Rastetter W, Molina A, White CA. Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med 2004;55:477-503.
4. Ahn YS, Lander G, Ahn ER, et al. Severe hypercoagulable state and concomitant life threatening bleeding successfully treated with Rituximab [abstract]. Blood 2003;102:108-109.
5. Tripodi A, Chantarangkul V, Clerici M, Mannucci PM. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Thromb Haemost 2002;88:583-586.
6. Bidot CJ, Jy W, Horstman LL, et al. Factor VII/VIIa: a new antigen in the anti-phospholipid antibody syndrome. Br J Haematol 2003;120:618-626.